IOL Chemicals and Pharmaceuticals · NSE: IOLCP · BSE: 524164
Q4 FY26 results · Jan–Mar 2026
IOL Chemicals and Pharmaceuticals reported revenue from operations of ₹619.45 crore (up 17.4% from Q4 FY25) and net profit of ₹53.16 crore (up 69.2% from Q4 FY25) for Q4 FY26 (Jan–Mar 2026), on a consolidated basis.
| Item | Q4 FY26 | Q4 FY25 | YoY | Q3 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 619.45 | 527.78 | +17.4% | 580.39 | +6.7% |
| Other income | 1.84 | 4.53 | −59.4% | 5.29 | −65.2% |
| Total income | 621.29 | 532.31 | +16.7% | 585.68 | +6.1% |
| Profit before tax | 70.81 | 44.70 | +58.4% | 27.55 | +157.0% |
| Net profit for the period | 53.16 | 31.42 | +69.2% | 20.58 | +158.3% |
| EPS, basic (₹) | 1.81 | 1.07 | +69.2% | 0.70 | +158.6% |
| Net margin (%) | 8.6 | 6.0 | 3.5 |
| Item | Q4 FY26 | Q4 FY25 | YoY | Q3 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 619.45 | 527.78 | +17.4% | 580.39 | +6.7% |
| Other income | 1.74 | 4.52 | −61.5% | 5.29 | −67.1% |
| Total income | 621.19 | 532.30 | +16.7% | 585.68 | +6.1% |
| Profit before tax | 70.83 | 44.90 | +57.8% | 27.55 | +157.1% |
| Net profit for the period | 53.18 | 31.62 | +68.2% | 20.58 | +158.4% |
| EPS, basic (₹) | 1.81 | 1.08 | +67.6% | 0.70 | +158.6% |
| Net margin (%) | 8.6 | 6.0 | 3.5 |
Consolidated
- Filed with BSE
- 20 May 2026, 19:48 IST
- Board meeting
- 20 May 2026
- Period
- 01 Jan 2026 to 31 Mar 2026
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 20 May 2026, 19:48 IST
- Board meeting
- 20 May 2026
- Period
- 01 Jan 2026 to 31 Mar 2026
- Review status
- Unaudited
- Source
- XBRL filing on BSE